Cognition Therapeutics, Inc. Common Stock (CGTX) is a publicly traded Healthcare sector company. As of May 21, 2026, CGTX trades at $1.24 with a market cap of $97.55M and a P/E ratio of -3.98. CGTX moved +15.32% today. Year to date, CGTX is -7.86%; over the trailing twelve months it is +281.43%. Its 52-week range spans $0.22 to $3.83. Analyst consensus is buy with an average price target of $3.50. Rallies surfaces CGTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Cognition Therapeutics, Inc. Common Stock (CGTX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CGTX moved +15.32% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $1.24 |
| Market Cap | $97.55M |
| P/E Ratio | -3.98 |
| EPS | $-0.32 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.83 |
| 52-Week Low | $0.22 |
| Volume | 19.80K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-23.49M |
| Gross Margin | 0.00% |
2 analysts cover CGTX: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $3.50.